RT @doctorRBC: LNA043 - modified, recombinant human angiopoietin-like 3 (ANGPTL3) protein âï¸proof of concept trial
Tweet Content
LNA043 - modified, recombinant human angiopoietin-like 3 (ANGPTL3) protein
⭐️proof of concept trial on patients with articular cartilage lesions
⭐️regeneration of damaged cartilage
⭐️treatment effect in cartilage volume
⭐️phase IIb pending
Abs#POS0277
#EULAR2021 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off